Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Jan 03, 2017 $1.25 $1.30 $1.22 $1.28 235 290
Dec 30, 2016 $1.25 $1.26 $1.20 $1.22 329 473
Dec 29, 2016 $1.28 $1.29 $1.21 $1.25 340 256
Dec 28, 2016 $1.29 $1.39 $1.22 $1.29 909 256
Dec 27, 2016 $1.32 $1.32 $1.25 $1.29 258 724
Dec 23, 2016 $1.25 $1.35 $1.22 $1.33 447 488
Dec 22, 2016 $1.25 $1.25 $1.21 $1.21 141 143
Dec 21, 2016 $1.27 $1.27 $1.21 $1.21 301 838
Dec 20, 2016 $1.39 $1.43 $1.20 $1.24 860 976
Dec 19, 2016 $1.33 $1.33 $1.20 $1.21 189 211
Dec 16, 2016 $1.16 $1.29 $1.12 $1.29 377 697
Dec 15, 2016 $1.24 $1.25 $1.13 $1.17 568 656
Dec 14, 2016 $1.36 $1.44 $1.24 $1.24 388 521
Dec 13, 2016 $1.38 $1.38 $1.28 $1.32 257 817
Dec 12, 2016 $1.41 $1.44 $1.31 $1.33 403 943
Dec 09, 2016 $1.36 $1.38 $1.31 $1.33 239 642
Dec 08, 2016 $1.36 $1.39 $1.32 $1.37 184 435
Dec 07, 2016 $1.40 $1.42 $1.35 $1.38 196 640
Dec 06, 2016 $1.46 $1.50 $1.36 $1.40 329 811
Dec 05, 2016 $1.40 $1.47 $1.35 $1.47 318 165
Dec 02, 2016 $1.39 $1.42 $1.34 $1.35 285 439
Dec 01, 2016 $1.72 $1.75 $1.35 $1.41 1 392 217
Nov 30, 2016 $1.57 $1.57 $1.45 $1.47 285 851
Nov 29, 2016 $1.65 $1.67 $1.53 $1.55 369 586
Nov 28, 2016 $1.73 $1.75 $1.52 $1.60 599 158
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT